KardiaMobile 6L can be used to measure QT duration in COVID-19 patients - Cardiac Rhythm News

KardiaMobile 6L, which it describes in a press release as the world’s only six lead personal ECG.

A comparison of ECG-based home monitoring devices in adults with CHD, Cardiology in the Young

ECG Archives - Cardiac Rhythm News

KardiaStation

Home Monitoring of Cardiac Devices in the Era of COVID-19

Keeping patients safe: antipsychotic medication monitoring using a pocket-sized six lead ECG - Lifescience Industry News

ECG's Role in COVID-19 Patient Management

Alivecor Newsroom

Manual QT interval measurement with a smartphone-operated single-lead ECG versus 12-lead ECG: a within-patient diagnostic validation study in primary care

AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder